These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3459734)

  • 1. Release of leukotriene C4 by isolated, perfused rat small intestine in response to platelet-activating factor.
    Hsueh W; Gonzalez-Crussi F; Arroyave JL
    J Clin Invest; 1986 Jul; 78(1):108-14. PubMed ID: 3459734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of vasoactive substances released by platelet-activating factor in the rat perfused heart.
    Hu WM; Man RY
    Br J Pharmacol; 1991 Dec; 104(4):933-7. PubMed ID: 1810604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of platelet-activating factor on flow rate and eicosanoid release in the isolated perfused rat gastric vascular bed.
    Dembinska-Kiec A; Peskar BA; Muller MK; Peskar BM
    Prostaglandins; 1989 Jan; 37(1):69-91. PubMed ID: 2717778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists.
    Piper PJ; Stewart AG
    Br J Pharmacol; 1987 Apr; 90(4):771-83. PubMed ID: 3034369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary vasoconstriction in the rat, isolated perfused heart induced by platelet-activating factor is mediated by leukotriene C4.
    Piper PJ; Stewart AG
    Br J Pharmacol; 1986 Jul; 88(3):595-605. PubMed ID: 3091131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of the coronary vascular effects of platelet-activating factor in the rat perfused heart.
    Hu W; Kinnaird AA; Man RY
    Br J Pharmacol; 1991 May; 103(1):1097-102. PubMed ID: 1652337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential release of leukotrienes and norepinephrine in rat bowel after platelet-activating factor. A mechanistic study of platelet-activating factor-induced bowel necrosis.
    Hsueh W; Gonzalez-Crussi F; Arroyave JL
    Gastroenterology; 1988 Jun; 94(6):1412-8. PubMed ID: 3360262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of exogenous prostaglandins on the release of leukotriene C4-like immunoreactivity and on coronary flow in indomethacin-treated anaphylactic guinea-pig hearts.
    Aehringhaus U; Dembinska-Kiéc A; Peskar BA
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Jul; 326(4):368-74. PubMed ID: 6384796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of prostaglandin of E, F and I series, leukotriene C and platelet activating factor on amylase release from isolated rat pancreatic acini.
    Jaworek J; Konturek SJ
    J Physiol Pharmacol; 1993 Dec; 44(4):365-81. PubMed ID: 7510150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged pulmonary hypertension caused by platelet-activating factor and leukotriene C4 in the rat lung.
    Davidson D; Drafta D
    J Appl Physiol (1985); 1992 Sep; 73(3):955-61. PubMed ID: 1400062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of platelet-activating factor-induced cardiac depression in the isolated perfused rat heart.
    Stahl GL; Lefer AM
    Circ Shock; 1987; 23(3):165-77. PubMed ID: 2827906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actions of lipoxygenase metabolites in isolated rat lungs.
    Voelkel NF; Stenmark KR; Reeves JT; Mathias MM; Murphy RC
    J Appl Physiol Respir Environ Exerc Physiol; 1984 Sep; 57(3):860-7. PubMed ID: 6436213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-activating factor-induced ischemic bowel necrosis. An investigation of secondary mediators in its pathogenesis.
    Hsueh W; Gonzalez-Crussi F; Arroyave JL
    Am J Pathol; 1986 Feb; 122(2):231-9. PubMed ID: 3080895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-activating factor potentiates protamine-induced lung edema. Role of eicosanoids.
    Chen CR; Voelkel NF; Chang SW
    Am J Respir Crit Care Med; 1994 Jan; 149(1):34-40. PubMed ID: 8111595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responses to leukotriene C4 in the perfused rat lung.
    Iacopino VJ; Compton S; Fitzpatrick T; Ramwell P; Rose J; Kot P
    J Pharmacol Exp Ther; 1984 Jun; 229(3):654-7. PubMed ID: 6427447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of tissue-type plasminogen activator is induced in rats by leukotrienes C4 and D4, but not by prostaglandins E1, E2 and I2.
    Tranquille N; Emeis JJ
    Br J Pharmacol; 1988 Jan; 93(1):156-64. PubMed ID: 3126847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Airway responsiveness in transgenic mice overexpressing platelet-activating factor receptor. Roles of thromboxanes and leukotrienes.
    Nagase T; Ishii S; Katayama H; Fukuchi Y; Ouchi Y; Shimizu T
    Am J Respir Crit Care Med; 1997 Nov; 156(5):1621-7. PubMed ID: 9372685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the coronary vascular responses to platelet-activating factor in the isolated perfused heart.
    Hu WM; Choy PC; Man RY
    Lipids; 1991 Sep; 26(9):700-4. PubMed ID: 1762514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-activating factor stimulation of peptidoleukotriene release: inhibition by vasoactive polypeptide.
    Beaubien BB; Tippins JR; Morris HR
    Biochem Biophys Res Commun; 1984 Nov; 125(1):105-8. PubMed ID: 6594998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of leukotriene C4 in pulmonary hypertension: platelet-activating factor vs. hypoxia.
    Davidson D; Singh M; Wallace GF
    J Appl Physiol (1985); 1990 Apr; 68(4):1628-33. PubMed ID: 2112129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.